Tag: platelet aggregation devices market insights

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The platelet aggregation devices market is experiencing remarkable growth driven by advancements in medical diagnostics and increasing prevalence of chronic diseases. As healthcare systems worldwide focus on better disease management and rapid diagnostic solutions, this sector is poised for significant expansion. Let’s explore the market’s current value, key growth drivers, segment classifications, emerging innovations, major players, and regional performance.

Steady Market Expansion Expected for Platelet Aggregation Devices

The platelet aggregation devices market has shown rapid growth in recent years and is forecasted to continue this trajectory. The market value is projected to rise from $1.04 billion in 2025 to $1.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 25.4%. The market’s previous expansion has been primarily fueled by an increase in cardiovascular disease cases, the proliferation of clinical diagnostic labs, broader use of antiplatelet therapies, heightened demand for coagulation testing, and progress in hematology diagnostic technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

Long-Term Growth Outlook for the Platelet Aggregation Devices Market

Looking further ahead, the market is expected to reach $2.94 billion by 2030, growing at a CAGR of 22.5%. This anticipated growth is driven by factors such as rising adoption of personalized medicine approaches, growing investments in advanced diagnostic tools, increasing demand for rapid platelet function tests, continuous research into blood disorders, and ongoing innovation in diagnostic technology. Key trends expected to influence the market include wider use of automated platelet function analyzers, demand for high-throughput testing platforms, integration of digital data management systems, expansion of multi-channel aggregation devices, and a sharper focus on enhancing diagnostic accuracy.

Rising Prevalence of Target Diseases Boosts Market Demand

One of the primary forces driving the platelet aggregation devices market is the increasing incidence of target diseases, which include critical conditions such as cancer, cardiovascular diseases, and diabetes. These devices play a vital role in early detection and management of thrombotic risks, helping to reduce complications like heart attacks and strokes in vulnerable populations. For example, in February 2024, the International Agency for Research on Cancer (IARC) reported that approximately 20 million new cancer cases and 9.7 million deaths occurred globally in 2022, with projections forecasting a 77% surge to over 35 million new cases by 2050. Lung cancer was the most common, with 2.5 million new diagnoses, followed by female breast, colorectal, prostate, and stomach cancers. Such alarming statistics highlight why the demand for platelet aggregation devices remains strong.

Access The Complete Platelet Aggregation Devices Market Report:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

How Target Disease Trends Are Shaping Market Dynamics

The rising burden of these diseases underscores the need for advanced diagnostic tools that can facilitate timely intervention. Platelet aggregation devices contribute significantly by enabling healthcare providers to monitor platelet function effectively, which is crucial in managing thrombotic conditions. As efforts to combat these diseases intensify globally, the demand for reliable and efficient platelet aggregation testing solutions continues to expand, directly influencing market growth.

Breaking Down the Platelet Aggregation Devices Market Structure

The market is segmented into various categories to better understand consumer needs and technological preferences. These include:

1) Product Types: Reagents, Systems, Consumables and Accessories

2) Channel Configuration: Four Channel, Dual Channel, Eight Channel

3) Technology Used: Optical, Impedance, Other Technologies

4) Application Areas: Clinical Applications, Research Applications, Cardiovascular Applications, Other Applications

5) End-Users: Standalone Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Other End Users

Within these segments, subcategories are detailed further, such as platelet aggregation assay reagents and coagulation/anticoagulation reagents under products, as well as testing systems that include platelet aggregation testing systems and automated systems. Consumables cover items like sample collection kits, testing plates, cuvettes, and calibration kits.

Innovation Trends Transforming the Platelet Aggregation Devices Market

Leading companies are focusing on developing state-of-the-art products to address supply challenges and improve diagnostic outcomes. A notable innovation is the introduction of the first platelet pooling set designed to stabilize the U.S. platelet supply and meet increasing clinical demands. Platelet pooling sets are specialized devices used in plateletpheresis to collect platelets from multiple donors into a single unit for transfusion. For instance, in February 2023, Terumo BCT Inc., a U.S.-based firm specializing in blood components and cellular technology, received FDA approval for its IMUGARD WB Platelet Pooling Set. This device offers extended platelet shelf life with seven-day storage clearance and enables platelet recovery from whole blood donations, enhancing supply flexibility. Such advancements are crucial for supporting critical medical procedures like chemotherapy and organ transplants, reflecting a significant leap forward in platelet aggregation technology.

Key Industry Players Leading the Market Competition

Several prominent companies dominate the platelet aggregation devices sector, including Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG and Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, and Instrumentation Laboratory. These organizations are key drivers of innovation and competitive growth.

Regional Market Overview and Growth Potential

In 2025, North America held the largest share of the platelet aggregation devices market, reflecting its advanced healthcare infrastructure and high adoption of diagnostic technologies. However, the Asia-Pacific region is anticipated to exhibit the fastest growth in the coming years, fueled by expanding healthcare access, increasing prevalence of chronic diseases, and growing investments in medical diagnostics. The market report also covers regions including South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Platelet Aggregation Devices Market Between 2026 And 2030?

The market for platelet aggregation devices has demonstrated rapid expansion in its size over recent years. A projected expansion indicates it will increase from $1.04 billion in 2025 to $1.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 25.4%. Factors such as the increasing prevalence of cardiovascular disease, the expansion of clinical diagnostic laboratories, the growing use of antiplatelet therapies, rising demand for coagulation testing, and advancements in hematology diagnostics are responsible for this growth during the historical period.

The platelet aggregation devices market size is anticipated to experience significant expansion over the next few years. It is forecast to grow to $2.94 billion by 2030, achieving a compound annual growth rate (CAGR) of 22.5%. This projected growth throughout the forecast period can be attributed to the rising acceptance of personalized medicine, increased investments in advanced diagnostics, a heightened demand for rapid platelet function testing, the broadening scope of research in blood disorders, and continuous innovation in diagnostic technologies. Prominent trends for the forecast period include the increasing implementation of automated platelet function analyzers, a growing need for high-throughput testing systems, the rising integration of digital data management, the expansion of multi-channel aggregation devices, and an intensified focus on diagnostic accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

What Significant Factors Are Influencing The Platelet Aggregation Devices Market Expansion?

A rise in the occurrence of target diseases is anticipated to propel the growth of the platelet aggregation devices market moving ahead. Target diseases refer to particular medical conditions, like cancer, cardiovascular diseases, and diabetes, which are prioritized for prevention, diagnosis, and treatment efforts because of their substantial effect on public health. These devices aid in reducing the prevalence of target diseases by facilitating prompt detection and efficient handling of thrombotic risks, thus averting severe outcomes such as heart attacks and strokes in at-risk groups. As an illustration, data released in February 2024 by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency under the World Health Organization (WHO), revealed that the globe experienced around 20 million new cancer cases and 9.7 million deaths in 2022. Forecasts suggest a 77% surge, leading to more than 35 million new cases by 2050. Globally, lung cancer was the most common with 2.5 million new cases (12.4%), succeeded by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Consequently, the rising occurrence of target diseases is propelling the expansion of the platelet aggregation devices market.

How Is The Platelet Aggregation Devices Market Segmented Across Different Segment Categories?

The platelet aggregation devices market covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Channel Configuration: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

What Trends Are Affecting The Direction Of The Platelet Aggregation Devices Market?

Leading companies in the platelet aggregation devices market are increasingly concentrating on developing advanced solutions by introducing innovative products, such as the initial platelet pooling set aimed at stabilizing the U.S. platelet supply and addressing growing needs. A platelet pooling set is a specialized medical instrument utilized during plateletpheresis procedures to collect and consolidate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, Terumo BCT Inc., a US-based firm specializing in blood components and cellular technology, announced that the Food and Drug Administration (FDA), a US-based federal agency, had approved its IMUGARD WB Platelet Pooling Set. This development provides an extended shelf life for platelets, FDA clearance for seven-day storage, and allows for platelet recovery from whole blood donations, thereby boosting flexibility and availability in the platelet aggregation devices market. This launch signifies a substantial technological leap by tackling the necessity for enhanced platelet availability, more efficient supply management, and supporting the strained U.S. platelet supply to meet increasing demand in crucial medical procedures like chemotherapy and organ transplants.

Which Organizations Play A Role In The Platelet Aggregation Devices Market Landscape?

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory

Get The Full Platelet Aggregation Devices Market Report:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Which Region Dominates The Platelet Aggregation Devices Market By Market Share?

North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Platelet Aggregation Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2026, By The Business Research Company

Platelet Rich Plasma Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-rich-plasma-global-market-report

Platelet Shaker Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report

Thrombectomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/thrombectomy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Platelet Aggregation Devices Market Expected To Change Between 2026 And 2030?

The market for platelet aggregation devices has shown significant expansion in recent years. This sector is projected to increase from $1.04 billion in 2025 to $1.31 billion in 2026, achieving a compound annual growth rate (CAGR) of 25.4%. Historically, this growth can be ascribed to several factors, including growth in cardiovascular disease prevalence, expansion of clinical diagnostic laboratories, increasing use of antiplatelet therapies, rising demand for coagulation testing, and advancements in hematology diagnostics.

The platelet aggregation devices market size is anticipated to experience substantial expansion over the next few years. It is projected to achieve a value of $2.94 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 22.5%. This growth throughout the forecast period stems from the increasing adoption of personalized medicine, greater investments in advanced diagnostics, a rising requirement for rapid platelet function testing, an increase in research concerning blood disorders, and ongoing innovations in diagnostic technologies. Significant trends during the forecast period include the expanding use of automated platelet function analyzers, a growing need for high-throughput testing systems, increasing integration of digital data management, the proliferation of multi-channel aggregation devices, and an intensified focus on diagnostic accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

What Underlying Factors Are Accelerating The Growth Of The Platelet Aggregation Devices Market?

The rising occurrence of target diseases is projected to propel the platelet aggregation devices market forward. Target diseases are specific health conditions, such as cancer, cardiovascular diseases, and diabetes, which receive focused prevention, diagnosis, and treatment efforts due to their substantial public health impact. Platelet aggregation devices contribute to reducing the incidence of these target diseases by enabling early detection and effective management of thrombotic risks, thereby preventing complications like heart attacks and strokes among susceptible populations. For example, in February 2024, data released by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), revealed that the world experienced approximately 20 million new cancer cases and 9.7 million deaths in 2022. Projections indicate a 77% increase to over 35 million new cases by 2050. Lung cancer was the most common globally with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Therefore, the increasing prevalence of target diseases is driving the expansion of the platelet aggregation devices market.

How Is The Platelet Aggregation Devices Market Structured Across Different Segments?

The platelet aggregation devices market covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Channel Configuration: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Which Trends Are Shaping The Future Of The Platelet Aggregation Devices Market?

Leading companies within the platelet aggregation devices market are intensifying their efforts to develop advanced solutions, notably by introducing innovative products such as the inaugural platelet pooling set, designed to help stabilize the U.S. platelet supply and meet increasing requirements. A platelet pooling set is a specialized medical instrument utilized in plateletpheresis procedures to gather and concentrate platelets from multiple donors into a single unit for transfusion therapy. For example, in February 2023, Terumo BCT Inc., a US-based company specializing in blood components and cellular technology, announced the approval of its IMUGARD WB Platelet Pooling Set by the Food and Drug Administration (FDA), a US-based federal agency. This innovation offers an extended shelf life for platelets, with FDA clearance for seven-day storage, and enables the recovery of platelets from whole blood donations, thereby enhancing flexibility and availability in the platelet aggregation devices market. This product launch signifies a considerable technological advancement by addressing the demand for improved platelet availability, more efficient supply management, and supporting the strained U.S. platelet supply to fulfill increasing needs in critical medical procedures like chemotherapy and organ transplants.

Which Major Players Dominate The Platelet Aggregation Devices Market?

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory

Read the full platelet aggregation devices market report here:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Which Region Is Projected To Dominate The Platelet Aggregation Devices Market During The Forecast Period?

North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Platelet Aggregation Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2026, By The Business Research Company

Platelet Rich Plasma Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-rich-plasma-global-market-report

Platelet Shaker Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report

Thrombectomy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/thrombectomy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Platelet Aggregation Devices Market from 2026 to 2030?

The platelet aggregation devices market has seen substantial growth in recent years. Projections indicate an increase from $1.04 billion in 2025 to $1.31 billion in 2026, with a compound annual growth rate (CAGR) of 25.4%. Historically, this market expansion has been driven by factors such as the rising prevalence of cardiovascular disease, the proliferation of clinical diagnostic laboratories, the greater use of antiplatelet therapies, an elevated demand for coagulation testing, and progress in hematology diagnostics.

The platelet aggregation devices market size is anticipated to expand significantly over the coming years, reaching $2.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.5%. This growth during the forecast period is primarily driven by the increasing adoption of personalized medicine, greater investments in advanced diagnostics, a surging demand for rapid platelet function testing, expanded research into blood disorders, and continuous innovation within diagnostic technologies. Additionally, prominent trends during this period include the wider acceptance of automated platelet function analyzers, a rising demand for high-throughput testing systems, increasing integration of digital data management, the proliferation of multi-channel aggregation devices, and an enhanced focus on diagnostic accuracy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

What Drivers Are Affecting Demand In The Platelet Aggregation Devices Market?

The escalating occurrence of target diseases is anticipated to propel the platelet aggregation devices market ahead. These target diseases represent particular health conditions emphasized in prevention, diagnosis, and treatment initiatives, given their substantial influence on public health, encompassing conditions like cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices aid in reducing the prevalence of target diseases through facilitating prompt detection and efficient management of thrombotic hazards, consequently averting serious complications such as heart attacks and strokes among susceptible groups. As an illustration, data released in February 2024 by the International Agency for Research on Cancer (IARC), a specialized cancer agency of the World Health Organization (WHO) situated in France, revealed that roughly 20 million new cancer cases and 9.7 million fatalities occurred worldwide in 2022. Forecasts suggest a 77% surge, leading to more than 35 million new cases by 2050. Globally, lung cancer accounted for the highest number of new cases at 2.5 million (12.4%), succeeded by female breast cancer with 2.3 million cases (11.6%), colorectal cancer at 1.9 million cases (9.6%), prostate cancer with 1.5 million (7.3%), and stomach cancer tallying 970,000 (4.9%). Consequently, the rising occurrence of target diseases is fueling the expansion of the platelet aggregation devices market.

Which Segments Are Gaining Traction In The Platelet Aggregation Devices Market?

The platelet aggregation devices market covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Channel Configuration: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

What Trends Are Reshaping The Dynamics Of The Platelet Aggregation Devices Market?

Leading companies in the platelet aggregation devices market are increasingly focusing on developing advanced solutions, introducing innovative products like the first platelet pooling set to stabilize the U.S. platelet supply and satisfy growing demands. A platelet pooling set is a specialized medical instrument utilized during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For example, in February 2023, Terumo BCT Inc., a US-based firm providing blood components and cellular technology, announced that the Food and Drug Administration (FDA), a US-based federal agency, had approved its IMUGARD WB Platelet Pooling Set. This innovation extends the shelf life for platelets, offering FDA clearance for seven-day storage, and allows for platelet recovery from whole blood donations, thereby enhancing flexibility and availability within the platelet aggregation devices market. This product launch signifies a considerable technological advancement by addressing the need for improved platelet availability, more efficient supply chain management, and bolstering the strained U.S. platelet supply to meet the rising demand in crucial medical procedures such as chemotherapy and organ transplants.

Who Are The Core Companies Influencing Trends In The Platelet Aggregation Devices Market?

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Platelet Aggregation Devices Market?

North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Platelet Aggregation Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2026, By The Business Research Company

Platelet Rich Plasma Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-rich-plasma-global-market-report

Platelet Shaker Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report

Thrombectomy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/thrombectomy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the platelet aggregation devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Platelet Aggregation Devices Market In The Period 2029-2034?

The market for platelet aggregation devices has experienced rapid expansion over recent years. It is anticipated to expand from $0.83 billion in 2024 to $1.04 billion in 2025, with a compound annual growth rate (CAGR) of 24.9%. The historical growth of this market can be attributed to factors such as the increasing prevalence of cardiovascular diseases, a rise in the incidence of bleeding disorders, growing awareness about health diagnostics, an increase in surgical procedures, and improved diagnostic accuracy.

The platelet aggregation devices market is set for significant expansion over the next few years. It is predicted to reach $2.46 billion by 2029, growing at a compound annual growth rate (CAGR) of 23.9%. This projected increase during the forecast period is largely driven by a demographic shift towards an older population, an increasing demand for point-of-care testing, the wider adoption of personalized medicine, supportive regulatory environments and approvals, and a rising prevalence of chronic health conditions. Notable developments anticipated in this period include the incorporation of artificial intelligence into diagnostic tools, the creation of portable platelet aggregation devices, enhanced collaborations between biotechnology firms and healthcare providers, the growing importance of data analytics in healthcare, and a shift towards diagnostic solutions for home use.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

What Strategic Drivers Are Accelerating The Platelet Aggregation Devices Market Expansion?

The platelet aggregation devices market is anticipated to expand due to the rising occurrence of target diseases. These target diseases refer to particular medical conditions, such as cancer, cardiovascular diseases, and diabetes, which are prioritized for prevention, diagnosis, and treatment owing to their significant public health impact. Platelet aggregation devices contribute to reducing the prevalence of these target diseases by facilitating prompt detection and efficient management of thrombotic risks, thereby averting severe complications like heart attacks and strokes in at-risk groups. As an illustration, figures released in February 2024 by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), revealed around 20 million new cancer cases and 9.7 million deaths globally in 2022. Forecasts suggest a 77% surge, leading to over 35 million new cases by 2050. Lung cancer emerged as the most widespread worldwide with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Consequently, the increasing incidence of target diseases is fueling the expansion of the platelet aggregation devices market.

What Is The Detailed Segment Distribution Of The Platelet Aggregation Devices Market?

The platelet aggregation devicesmarket covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Type: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Which Market Trends Are Expected To Define The Future Of The Platelet Aggregation Devices Market?

Companies operating in the platelet aggregation devices market are intensifying their efforts to develop sophisticated solutions, introducing innovative products like the first platelet pooling set aimed at stabilizing the U.S. platelet supply and fulfilling growing requirements. A platelet pooling set is a specialized medical instrument employed during plateletpheresis procedures to collect and concentrate platelets from multiple donors into one unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC., a US-based company specializing in blood components and cellular technology, announced the Food and Drug Administration (FDA), a US-based federal agency, had approved the IMUGARD WB Platelet Pooling Set. This product offers an extended shelf life for platelets, FDA clearance for seven-day storage, and enables platelet recoupment from whole blood donations, thereby enhancing flexibility and availability within the platelet aggregation devices market. This launch marks a significant technological advancement by addressing the need for improved platelet availability, more efficient supply management, and supporting the strained U.S. platelet supply to meet increasing demand in crucial medical procedures such as chemotherapy and organ transplants.

Who Are The Major Stakeholders Operating In The Platelet Aggregation Devices Market?

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Platelet Aggregation Devices Market?

North America was the largest region in the platelet aggregation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2025, By The Business Research Company

Platelet Shaker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report

Blood Preparation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report

Blood Pressure Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-pressure-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Platelet Aggregation Devices Market By 2029?

The global market for platelet aggregation testing apparatus has seen substantial expansion lately, projected to increase its valuation from $0.83 billion in the year 2024 to $1.04 billion by 2025, reflecting a compound annual growth rate of 24.9%. This significant upward trend noted during the historical timeframe stems from several key factors, including the escalating occurrence of cardiac illnesses, a higher frequency of blood clotting or bleeding irregularities being reported, heightened public and professional recognition regarding necessary health screenings, a greater number of operations being performed, and enhancements in the precision of diagnostic methodologies.

Exponential expansion is projected for the platelet aggregation devices market in the upcoming years, with its valuation predicted to reach $2.46 billion by 2029, achieving a compound annual growth rate (CAGR) of 23.9%; this substantial upward trajectory during the forecast is fueled by several factors, including the expanding elderly demographic, escalating need for testing administered at the point of care, the advancement of tailored medical treatments, favorable regulatory backing and official sanctioning, alongside the increasing incidence rates of long-term illnesses, while key developments shaping this period encompass the incorporation of artificial intelligence into diagnostic procedures, the creation of mobile platelet aggregation instruments, heightened partnerships between biotechnology enterprises and medical service providers, the growing significance placed on data analysis within healthcare systems, and a transition toward diagnostic assessment conducted from home settings.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

Which Industry Drivers Are Expected To Accelerate The Platelet Aggregation Devices Market From 2025 To 2029?

The projected expansion of the market for platelet aggregation devices is largely attributed to the rising prevalence of specific medical conditions that necessitate concentrated diagnostic and therapeutic focus, such as diabetes, cardiovascular ailments, and oncological disorders. These devices play a crucial role in mitigating the impact of these prevalent diseases by facilitating the timely identification and robust management of thrombosis risks, which in turn aids in averting severe outcomes such as strokes and heart attacks within at-risk groups. Supporting this trend, the International Agency for Research on Cancer (IARC), the specialized cancer entity of the World Health Organization based in France, released data in February 2024 showing that the globe recorded around 20 million new cancer diagnoses and 9.7 million fatalities in 2022, with estimates suggesting a substantial 77 percent surge to beyond 35 million new instances by 2050; lung cancer represented the largest affected category worldwide, accounting for 2.5 million new diagnoses (12.4 percent), closely followed by female breast cancer (2.3 million cases, 11.6 percent), colorectal cancer (1.9 million cases, 9.6 percent), prostate cancer (1.5 million cases, 7.3 percent), and stomach cancer (970,000 cases, 4.9 percent). Consequently, this escalating frequency of key health threats propels the forward momentum of the platelet aggregation apparatus market.

What Are The Emerging Segments Gaining Attention In The Platelet Aggregation Devices Market?

The platelet aggregation devicesmarket covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Type: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

What Long-Term Trends Will Shape The Future Growth Of The Platelet Aggregation Devices Industry?

Leading entities within the platelet aggregation devices sector are intensifying efforts to create cutting-edge offerings, highlighted by the introduction of novel tools like the inaugural platelet pooling set, designed precisely to bolster the stability of the American platelet inventory and satisfy escalating requirements. This platelet pooling set functions as a dedicated apparatus in apheresis processes, gathering and concentrating platelets sourced from several donors into a solitary unit destined for transfusion support. To illustrate, February 2023 saw TERUMO BCT INC., an American firm specializing in cellular and blood component technologies, successfully secure authorization from the United States Food and Drug Administration (FDA) for its IMUGARD WB Platelet Pooling Set; this clearance permits platelets to be stored for a full week, thereby extending their usability, and concurrently allows for the recovery of platelets from whole blood donations, boosting adaptability and accessibility across the market for platelet aggregation devices. The debut of this product signifies a major leap forward in technology, effectively tackling the challenges related to better platelet supplies, optimizing inventory oversight, and reinforcing the often-strained U.S. platelet stock to serve the rising necessity for transfusions in vital medical interventions, chemotherapy being a prime example, alongside procedures such as organ transplants.

Who Are The Top Performing Companies In The Platelet Aggregation Devices Market In Recent Years?

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

What Regional Growth Trends Are Shaping The Platelet Aggregation Devices Market Outlook?

North America was the largest region in the platelet aggregation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Platelet Aggregation Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2025, By The Business Research Company

Platelet Shaker Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report

Blood Preparation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report

Blood Pressure Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-pressure-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Platelet Aggregation Devices Market Size Shifted, And What Is the Outlook Through 2034?

The market size for platelet aggregation devices has seen exponential growth in the past years. There will be an increase from $0.83 billion in 2024 to $1.04 billion in 2025, representing a compound annual growth rate (CAGR) of 24.9%. The substantial growth in the historical phase is due to an escalated prevalence of heart diseases, an increase in cases of bleeding disorders, heightened awareness regarding health diagnostics, a surge in surgical procedures, and improved diagnostic accuracy.

The market size for platelet aggregation devices is anticipated to grow exponentially in the coming years, surging to $2.46 billion in 2029 with a compound annual growth rate (CAGR) of 23.9%. Numerous factors can be credited for this growth during the forecast period, such as the ever-growing elderly population, increased requirement for point-of-care testing, the rise of personalized medicine, regulatory support and authorizations, and a growing number of chronic diseases. The forecast period also identifies key trends such as the utilization of artificial intelligence in diagnosis, the creation of portable platelet aggregation gadgets, enhanced collaboration of biotech firms with healthcare providers, the escalating relevance of data analytics in healthcare, and a shift towards home-based diagnostic measures.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

Which Primay Drivers Are Accelerating Growth in the Platelet Aggregation Devices Market?

The expected rise in specific diseases, referred to as target diseases, is likely to boost the growth of the platelet aggregation devices market. Such target diseases include medical conditions like cancer, cardiovascular diseases, and diabetes that have a significant impact on public health and are prioritised for prevention, treatment, and diagnosis. These devices pave the way for early identification and efficient management of thrombotic risks, thereby preventing complex health issues such as heart attacks and strokes in susceptible individuals. For instance, according to data released by the International Agency for Research on Cancer (IARC), a specialised cancer agency within the World Health Organization (WHO) based in France, around 20 million new cancer cases and 9.7 million deaths were reported in 2022, and the forecast suggests a staggering increase of 77% to above 35 million new cases by 2050. Lung cancer topped the list with 2.5 million new cases (12.4%), trailed by breast cancer in females (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Hence, the surge in target diseases is fuelling growth in the platelet aggregation devices market.

Which Primary Segments of the Platelet Aggregation Devices Market Are Driving Growth and Industry Transformations?

The platelet aggregation devicesmarket covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Type: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Platelet Aggregation Devices Market?# Market?

North America was the largest region in the platelet aggregation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Platelet Aggregation Devices Industry Dynamics?

Major firms active in the platelet aggregation devices market are shifting their attention to the development of sophisticated solutions, launching groundbreaking products such as the first platelet pooling set to solidify the U.S. platelet supply and cater to escalating demands. A platelet pooling set is a distinct medical tool employed during plateletpheresis operations to amass and enrich platelets from multiple donors into a solitary unit for transfusion therapy. For example, in February 2023, TERUMO BCT INC., an American company specializing in blood components and cellular technology, hailed FDA approval for the IMUGARD WB Platelet Pooling Set. This provided an elongated shelf life for platelets, FDA sanction for seven-day storage, along with the facilitation of platelet recovery from whole blood contributions, boosting flexibility and accessibility in the platelet aggregation devices market. This introduction signifies a crucial technical progression by fulfilling the requirement for enhanced platelet availability, optimizing supply distribution, and backing the pressured U.S. platelet supply in fulfilling the growing need in vital medical processes such as chemotherapy and organ transplants.

View the full report here:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

What Parameters Are Used to Define the Platelet Aggregation Devices Market?

Platelet aggregation devices are specialized instruments used to measure the rate and extent to which platelets clump together, which is crucial for diagnosing and managing disorders related to blood clotting. These devices are used to assess the effectiveness of antiplatelet therapies, diagnose bleeding disorders, and evaluate platelet function in various clinical and research settings.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15896

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Fast Is The Platelet Aggregation Devices Market Expected to Grow Between 2025 And 2029?#_x000D_

The market size of platelet aggregation devices has observed a significant expansion over the past years. The market value, which stood at $0.83 billion in 2024, is anticipated to rise to $1.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 25.8%. The observed growth during the historical period is due to a surge in cardiovascular diseases, escalating instances of bleeding disorders, heightened awareness regarding health diagnostics, a rise in the number of surgical procedures, and enhanced diagnostic precision._x000D_

_x000D_

#What Growth Rate Is Anticipated for the Platelet Aggregation Devices Market in the Coming Years?#_x000D_

The market size for platelet aggregation devices is set to experience a significant surge in the coming years, reaching a remarkable sum of $2.59 billion in 2029 with a compound annual growth rate (CAGR) of 25.4%. The predicted growth during the forecast period is primarily owing to increased aging population, higher demand for point-of-care testing, development of bespoke medicine, enhanced regulatory support and approvals, coupled with the climbing prevalence of chronic diseases. The main trends in the forecast period will focus on the incorporation of artificial intelligence in diagnostic procedures, the creation of portable platelet aggregation devices, augmented partnerships between biotech corporations and healthcare providers, the growing significance of data analytics in the healthcare sector, and a trend towards home-based diagnostic procedures._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp_x000D_

_x000D_

#Who Are the Leading Companies in the Platelet Aggregation Devices Market?#_x000D_

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago_x000D_

_x000D_

#What Are the Key Drivers of the Platelet Aggregation Devices Market?#_x000D_

The escalating prevalence of specific illnesses, known as target diseases, is anticipated to fuel the growth of the platelet aggregation devices market. These target diseases include crucial health conditions, like cancer, cardiovascular diseases, and diabetes, which are the primary subjects of early detection, prevention, and treatment due to their large scale impact on public health. Platelet aggregation devices play a crucial role in mitigating the occurrence of these diseases by facilitating early diagnosis and efficient handling of thrombotic risks, hence avoiding severe problems like heart attacks and strokes in susceptible individuals. For example, in February 2024, the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), reported around 20 million new incidents of cancer and 9.7 million fatalities in 2022, predicting a 77% spike to over 35 million new instances by 2050. The data showed that lung cancer had the highest prevalence worldwide with 2.5 million new cases (12.4%), followed by breast cancer in women (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Thus, the rising prevalence of target diseases is propelling the expansion of the platelet aggregation devices market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp_x000D_

_x000D_

#What Are the Key Market Segments in the Platelet Aggregation Devices Industry?#_x000D_

The platelet aggregation devices market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Reagents, Systems, Consumables And Accessories_x000D_

2) By Type: Four Channel, Dual Channel, Eight Channel_x000D_

3) By Technology: Optical, Impedance, Other Technologies_x000D_

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications_x000D_

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents_x000D_

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems_x000D_

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits_x000D_

_x000D_

#What Are the Latest Trends in the Platelet Aggregation Devices Market?#_x000D_

The key players in the platelet aggregation devices market are shifting their focus to create advanced solutions and introduce groundbreaking products, such as the pioneering platelet pooling set designed to bolster the U.S. platelet supply and satisfy escalating demands. The platelet pooling set is a unique medical device utilized in plateletpheresis procedures to amass and concentrate platelets from numerous donors into a solitary unit for transfusion therapy. For instance, TERUMO BCT INC., a U.S.-based firm that specializes in blood components and cellular technology, publicized the Food and Drug Administration (FDA) approval of the IMUGARD WB Platelet Pooling Set in February 2023. This product provides many benefits such as extended shelf life for platelets, FDA approval for a seven-day storage period, and the capacity to retrieve platelets from whole blood donations. These factors increase flexibility and accessibility in the platelet aggregation devices market. This debut signifies considerable technological progress by catering to the need for better platelet availability, streamlining supply management, and aiding the taut U.S. platelet supply to manage the growing requirements in vital medical procedures, such as chemotherapy and organ transplants._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report_x000D_

_x000D_

#What Are the Key Regional Markets in the Platelet Aggregation Devices Industry?#_x000D_

North America was the largest region in the platelet aggregation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15896_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the platelet aggregation devices market, and how is it changing globally?_x000D_

2. Who are the major companies in the platelet aggregation devices market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the platelet aggregation devices market right now?_x000D_

4. Which products or customer segments are growing the most in the platelet aggregation devices market?_x000D_

5. What factors are helping or slowing down the growth of the platelet aggregation devices market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the platelet aggregation devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Anticipated CAGR of the Platelet Aggregation Devices Market, and What Factors Will Drive It?

The market size of platelet aggregation devices has seen exponential growth in recent years. It is forecasted to rise from $0.83 billion in 2024 to $1.05 billion in 2025, representing a compound annual growth rate (CAGR) of 25.8%. The noteworthy growth in the previous period is accredited to the escalating prevalence of cardiovascular diseases, the upward trend in bleeding disorder cases, the enhanced awareness about health diagnostics, a rise in surgical procedures, and enhanced diagnostic accuracy.

The market for platelet aggregation devices is set to experience significant expansion in the coming years, predicted to reach a value of $2.59 billion by 2029, representing a compound annual growth rate (CAGR) of 25.4%. This growth trajectory through the forecast period is primarily driven by factors such as an ageing population, escalating demands for point-of-care testing, the surge in personalized medicine, and regulatory approvals and support, alongside the rise in chronic diseases. Key market trends expected during the forecast period features artificial intelligence’s inclusion in diagnostics, the emergence of portable platelet aggregation devices, heightened collaboration between biotech companies and healthcare service providers, the growing significance of data analytics in healthcare, and a shift towards diagnostics at home.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

What Are the Core Market Drivers Propelling Growth in the Platelet Aggregation Devices Industry?

The escalation in the prevalence of specific diseases of concern, called target diseases, is set to propel the growth of the platelet aggregation devices market. These target diseases – including cancer, cardiovascular diseases, and diabetes – carry a hefty weight on global health and are therefore prioritized in prevention, diagnosis, and treatment strategies. With their ability to early identify and effectively manage thrombotic risks, platelet aggregation devices play a crucial role in reducing the incidence of target diseases and forestalling severe complications such as heart attacks and strokes in susceptible individuals. For example, information released in February 2024 by the International Agency for Research on Cancer (IARC), a France-based cancer specialty agency under the World Health Organization (WHO), stated around 20 million new cancer incidences and 9.7 million related fatalities in 2022. Further projections anticipate a 77% surge to more than 35 million new cases by 2050. Lung cancer registered as the most common worldwide with 2.5 million new cases (12.4%), trailed by breast cancer in women (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Hence, the rising prevalence of these target diseases is fostering the expansion of the platelet aggregation devices market.

What Segment Types Define the Platelet Aggregation Devices Market Structure?

The platelet aggregation devices market covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Type: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Which Regions Are Driving the Next Phase of the Platelet Aggregation Devices Market Growth?

North America was the largest region in the platelet aggregation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering the Platelet Aggregation Devices Market Direction?

Key players in the platelet aggregation devices market are intensifying their efforts towards developing state-of-the-art solutions by introducing unique products such as the initial platelet pooling set aimed at stabilising the platelet supply in the U.S. and accommodating rising demands. A platelet pooling set is a sophisticated medical device used in plateletpheresis processes to aggregate and fortify platelets from numerous donors into a single unit for transfusion treatment. For instance, in February 2023, US-based TERUMO BCT INC., a firm specialising in blood components and cell technology, declared the endorsement of the IMUGARD WB Platelet Pooling Set by the US-based Food and Drug Administration (FDA). This product boasts an extended platelet shelf-life, a seven-day storage approval from the FDA, and facilitates the re-collection of platelets from whole blood donations—boosting adaptability and accessibility in the platelet aggregation devices market. This product launch symbolises a major technological progression by catering to the demand for enhanced platelet availability, effective supply management, and assisting the stretched U.S. platelet supply in meeting the growing need in critical medical practices such as chemotherapy and organ transplantation.

View the full report here:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

What Is the Definition of the Platelet Aggregation Devices Market?

Platelet aggregation devices are specialized instruments used to measure the rate and extent to which platelets clump together, which is crucial for diagnosing and managing disorders related to blood clotting. These devices are used to assess the effectiveness of antiplatelet therapies, diagnose bleeding disorders, and evaluate platelet function in various clinical and research settings.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15896

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of thePlatelet Aggregation Devices Market?

The rising incidence of target diseases is expected to support the growth of the platelet aggregation devices market. Target diseases like cancer, cardiovascular diseases, and diabetes are major health concerns. Platelet aggregation devices help manage thrombotic risks and prevent complications such as strokes and heart attacks. The International Agency for Research on Cancer reported 20 million new cancer cases in 2022, with projections showing a 77% increase by 2050. Therefore, the rising incidence of target diseases is fueling the growth of the platelet aggregation devices market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

#What is the Anticipated CAGR of thePlatelet Aggregation Devices Market, and What Factors Will Drive It?

The platelet aggregation devices market size surged, growing from $0.83 billion in 2024 to $1.05 billion in 2025 at a CAGR of 25.8%, owing to cardiovascular and bleeding disorder prevalence, diagnostic awareness, surgical procedures, and improved accuracy.

The platelet aggregation devices market is expected to see exponential growth, reaching $2.59 billion in 2029 at a CAGR of 25.4%. The growth is driven by an aging population, demand for point-of-care testing, personalized medicine expansion, regulatory support, and chronic disease prevalence. Key trends include AI integration, portable devices, biotech and healthcare collaborations, data analytics in healthcare, and home-based diagnostics.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15896

What Key Market Trends and Innovations Are Shaping the Future of thePlatelet Aggregation Devices Industry?

Major companies in the platelet aggregation devices market are focusing on developing advanced solutions, such as the first platelet pooling set, to stabilize the U.S. platelet supply and meet rising demand. A platelet pooling set is used in plateletpheresis to collect and concentrate platelets from multiple donors into a single unit for transfusion. For example, in February 2023, TERUMO BCT INC., a U.S.-based company specializing in blood components, announced FDA approval for the IMUGARD WB Platelet Pooling Set. This set extends the shelf life of platelets, offering FDA clearance for seven-day storage and enabling platelet recoupment from whole blood donations, improving platelet availability and flexibility in critical medical procedures like chemotherapy and organ transplants.

Which Companies Are Leading the Charge in Expanding thePlatelet Aggregation Devices Market Growth?

Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

How is the Global Platelet Aggregation Devices Market Segemented?

The platelet aggregation devices market covered in this report is segmented –

1) By Product: Reagents, Systems, Consumables And Accessories

2) By Type: Four Channel, Dual Channel, Eight Channel

3) By Technology: Optical, Impedance, Other Technologies

4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications

5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents

2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems

3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15896&type=smp

Which Geographics are Influencing the Growth of the Platelet Aggregation Devices Market?

North America was the largest region in the platelet aggregation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Platelet Aggregation Devices Market 2025, By The Business Research Company:

Blood Warmers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-warmers-global-market-report

Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Blood Preparation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: